RAC 2.10% $1.40 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-21

  1. 427 Posts.
    lightbulb Created with Sketch. 206
    The discussions with Dr Sabnis were new to me. No weight attached to these until pen gets put to paper but it's nice to know RAC are looking at all/any chances of driving bisantrene to market.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.